RecruitingPhase 1 / Phase 2NCT06162221
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Sponsor: Revolution Medicines, Inc.
Houston, TX · Irving, TX · +27 more sites
Lung Cancer clinical trials in Irving, TX
11 recruiting lung cancer studies with a site in Irving, TX.
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Austin, TX · Dallas, TX · +42 more sites
RecruitingPhase 1NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Sponsor: Astellas Pharma Inc
Irving, TX · +10 more sites
RecruitingPhase 3NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +238 more sites
RecruitingPhase 3NCT07222566
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Pfizer
Abilene, TX · Allen, TX · Amarillo, TX · +223 more sites
RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
Irving, TX · +6 more sites
RecruitingPhase 1NCT07578571
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Sponsor: Immunome, Inc.
Irving, TX · +3 more sites
RecruitingPhase 1NCT07277413
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Fort Worth, TX · Houston, TX · +20 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Austin, TX · Houston, TX · Irving, TX · +15 more sites
RecruitingPhase 1NCT07241039
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
Sponsor: AbbVie
Irving, TX · +5 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Houston, TX · +103 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.